- Home
- PYPD vs HFBL Comparison
PYPD vs HFBL Comparison
Compare PYPD & HFBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- HFBL
- Stock Information
- Founded
- PYPD 2008
- HFBL 1924
- Country
- PYPD Israel
- HFBL United States
- Employees
- PYPD N/A
- HFBL N/A
- Industry
- PYPD Medical/Dental Instruments
- HFBL Savings Institutions
- Sector
- PYPD Health Care
- HFBL Finance
- Exchange
- PYPD Nasdaq
- HFBL Nasdaq
- Market Cap
- PYPD 34.8M
- HFBL 41.6M
- IPO Year
- PYPD 2020
- HFBL N/A
- Fundamental
- Price
- PYPD N/A
- HFBL N/A
- Analyst Decision
- PYPD Strong Buy
- HFBL
- Analyst Count
- PYPD 5
- HFBL 0
- Target Price
- PYPD $12.00
- HFBL N/A
- AVG Volume (30 Days)
- PYPD 49.5K
- HFBL 2.0K
- Earning Date
- PYPD 11-12-2025
- HFBL 10-28-2025
- Dividend Yield
- PYPD N/A
- HFBL 3.78%
- EPS Growth
- PYPD N/A
- HFBL 7.69
- EPS
- PYPD N/A
- HFBL 1.26
- Revenue
- PYPD N/A
- HFBL $20,802,000.00
- Revenue This Year
- PYPD N/A
- HFBL N/A
- Revenue Next Year
- PYPD N/A
- HFBL N/A
- P/E Ratio
- PYPD N/A
- HFBL $11.10
- Revenue Growth
- PYPD N/A
- HFBL 1.50
- 52 Week Low
- PYPD $2.30
- HFBL $11.75
- 52 Week High
- PYPD $3.93
- HFBL $14.34
- Technical
- Relative Strength Index (RSI)
- PYPD 45.84
- HFBL 63.50
- Support Level
- PYPD $3.34
- HFBL $13.70
- Resistance Level
- PYPD $3.57
- HFBL $13.73
- Average True Range (ATR)
- PYPD 0.13
- HFBL 0.08
- MACD
- PYPD -0.00
- HFBL 0.05
- Stochastic Oscillator
- PYPD 31.25
- HFBL 100.00
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.